Dr. Caroline Lee Wallner, MD

Dr. Wallner practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Wallner's NPI, 1114169760, was assigned on March 28, 2009. Dr. Wallner graduated from David Geffen School of Medicine at UCLA in 2009. Dr. Wallner holds California license A113187.

Dr. Wallner's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Wallner's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Wallner is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Urology. Dmand AI also links Dr. Wallner to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wallner practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Wallner's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Wallner is board certified in urology by the American Board of Urology. Dr. Wallner is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, prostate inflammation or infection, testicular dysfunction and urinary endoscopy among the conditions Dr. Wallner treats.

CMS data shows 1,130 Medicare services from Dr. Wallner across 8 procedure codes in 2024, for 404 Medicare patients. Medicare paid $72,179 for them. Every service was in an office.

CMS counts 404 Medicare patients who saw Dr. Wallner in 2024. The largest group is 65 to 74, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wallner's median patient age at 66, with 42% women.

In 2024, Dr. Wallner wrote 2,207 Medicare Part D claims for 547 patients. 88% of them were for generic drugs. CMS names the drug for 2,049 of them, across 32 drugs with 11 or more claims each, at $327,353 in total drug cost. In 2023, CMS named 2,161 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wallner for performance year 2024, reported as part of a group. Dr. Wallner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wallner as offering telehealth. CMS counts 21 procedures of prostate resection by Dr. Wallner, more than 83% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Wallner, published from 2013 to 2014. 2013 was the busiest year, with 2. The most frequent topics are Nephrostomy, Percutaneous. Dr. Wallner has published most often in J Endourol. Dr. Wallner's most frequent co-authors are Gene Omar Huang, MD, Gaudencio Olgin, MD and Kirk Anderson, MD.

CMS Open Payments shows 82 general payments to Dr. Wallner from 18 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 99% of the total. PROCEPT BioRobotics Corporation paid the most, $469.

Dr. Wallner graduated from David Geffen School of Medicine at UCLA in 2009. Dr. Wallner is a member of AUA.

Dr. Wallner is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.